3.26.1 html 280 408 1 false 81 0 false 12 false false R1.htm 0000001 - Document - Cover Sheet http://mirumpharma.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://mirumpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 9952152 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://mirumpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://mirumpharma.com/role/CondensedConsolidatedStatementsofOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://mirumpharma.com/role/CondensedConsolidatedStatementsofComprehensiveLossUnaudited Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 9952155 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Sheet http://mirumpharma.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityUnaudited Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Statements 6 false false R7.htm 9952156 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) (Parenthetical) Sheet http://mirumpharma.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityUnauditedParenthetical Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) (Parenthetical) Statements 7 false false R8.htm 9952157 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://mirumpharma.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 8 false false R9.htm 9952158 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) Sheet http://mirumpharma.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) Statements 9 false false R10.htm 9952159 - Disclosure - Organization and Description of Business Sheet http://mirumpharma.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 10 false false R11.htm 9952160 - Disclosure - Summary of Significant Accounting Policies Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 9952161 - Disclosure - Fair Value Measurements Sheet http://mirumpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 9952162 - Disclosure - Financial Instruments Sheet http://mirumpharma.com/role/FinancialInstruments Financial Instruments Notes 13 false false R14.htm 9952163 - Disclosure - Balance Sheet Components Sheet http://mirumpharma.com/role/BalanceSheetComponents Balance Sheet Components Notes 14 false false R15.htm 9952164 - Disclosure - Asset Acquisitions Sheet http://mirumpharma.com/role/AssetAcquisitions Asset Acquisitions Notes 15 false false R16.htm 9952165 - Disclosure - License Agreements Sheet http://mirumpharma.com/role/LicenseAgreements License Agreements Notes 16 false false R17.htm 9952166 - Disclosure - Leases Sheet http://mirumpharma.com/role/Leases Leases Notes 17 false false R18.htm 9952167 - Disclosure - Convertible Notes Notes http://mirumpharma.com/role/ConvertibleNotes Convertible Notes Notes 18 false false R19.htm 9952168 - Disclosure - Stockholders' Equity Sheet http://mirumpharma.com/role/StockholdersEquity Stockholders' Equity Notes 19 false false R20.htm 9952169 - Disclosure - Stock-Based Compensation Sheet http://mirumpharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 20 false false R21.htm 9952170 - Disclosure - Segment Reporting Sheet http://mirumpharma.com/role/SegmentReporting Segment Reporting Notes 21 false false R22.htm 9952171 - Disclosure - Commitments and Contingencies Sheet http://mirumpharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9955511 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://mirumpharma.com/role/SummaryofSignificantAccountingPolicies 24 false false R25.htm 9955512 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://mirumpharma.com/role/SummaryofSignificantAccountingPolicies 25 false false R26.htm 9955513 - Disclosure - Fair Value Measurements (Tables) Sheet http://mirumpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://mirumpharma.com/role/FairValueMeasurements 26 false false R27.htm 9955514 - Disclosure - Financial Instruments (Tables) Sheet http://mirumpharma.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://mirumpharma.com/role/FinancialInstruments 27 false false R28.htm 9955515 - Disclosure - Balance Sheet Components (Tables) Sheet http://mirumpharma.com/role/BalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://mirumpharma.com/role/BalanceSheetComponents 28 false false R29.htm 9955516 - Disclosure - Asset Acquisitions (Tables) Sheet http://mirumpharma.com/role/AssetAcquisitionsTables Asset Acquisitions (Tables) Tables http://mirumpharma.com/role/AssetAcquisitions 29 false false R30.htm 9955517 - Disclosure - Leases (Tables) Sheet http://mirumpharma.com/role/LeasesTables Leases (Tables) Tables http://mirumpharma.com/role/Leases 30 false false R31.htm 9955518 - Disclosure - Convertible Notes (Tables) Notes http://mirumpharma.com/role/ConvertibleNotesTables Convertible Notes (Tables) Tables http://mirumpharma.com/role/ConvertibleNotes 31 false false R32.htm 9955519 - Disclosure - Stockholders' Equity (Tables) Sheet http://mirumpharma.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://mirumpharma.com/role/StockholdersEquity 32 false false R33.htm 9955520 - Disclosure - Stock-Based Compensation (Tables) Sheet http://mirumpharma.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://mirumpharma.com/role/StockBasedCompensation 33 false false R34.htm 9955521 - Disclosure - Segment Reporting (Tables) Sheet http://mirumpharma.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://mirumpharma.com/role/SegmentReporting 34 false false R35.htm 9955522 - Disclosure - Organization and Description of Business (Details) Sheet http://mirumpharma.com/role/OrganizationandDescriptionofBusinessDetails Organization and Description of Business (Details) Details http://mirumpharma.com/role/OrganizationandDescriptionofBusiness 35 false false R36.htm 9955523 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash Reported Within the Consolidated Balance Sheets (Details) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashReportedWithintheConsolidatedBalanceSheetsDetails Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash Reported Within the Consolidated Balance Sheets (Details) Details 36 false false R37.htm 9955524 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 37 false false R38.htm 9955525 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregation of Total Product Sales (Details) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationofTotalProductSalesDetails Summary of Significant Accounting Policies - Schedule of Disaggregation of Total Product Sales (Details) Details 38 false false R39.htm 9955526 - Disclosure - Summary of Significant Accounting Policies - Schedule of Product Sales by Geographic Area (Details) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofProductSalesbyGeographicAreaDetails Summary of Significant Accounting Policies - Schedule of Product Sales by Geographic Area (Details) Details 39 false false R40.htm 9955527 - Disclosure - Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofComputationofBasicandDilutedNetLossPerShareDetails Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) Details 40 false false R41.htm 9955528 - Disclosure - Summary of Significant Accounting Policies - Schedule of Outstanding Potentially Dilutive Shares of Common Stock Excluded from Calculation of Diluted Net Loss Per Share (Details) Sheet http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofOutstandingPotentiallyDilutiveSharesofCommonStockExcludedfromCalculationofDilutedNetLossPerShareDetails Summary of Significant Accounting Policies - Schedule of Outstanding Potentially Dilutive Shares of Common Stock Excluded from Calculation of Diluted Net Loss Per Share (Details) Details 41 false false R42.htm 9955529 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities to Fair Value Measurements on Recurring Basis and Level of Input Measurements (Details) Sheet http://mirumpharma.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiestoFairValueMeasurementsonRecurringBasisandLevelofInputMeasurementsDetails Fair Value Measurements - Schedule of Financial Assets and Liabilities to Fair Value Measurements on Recurring Basis and Level of Input Measurements (Details) Details 42 false false R43.htm 9955530 - Disclosure - Fair Value Measures - Schedule of Changes in Estimated Fair Value of Holdback Liabilities (Details) Sheet http://mirumpharma.com/role/FairValueMeasuresScheduleofChangesinEstimatedFairValueofHoldbackLiabilitiesDetails Fair Value Measures - Schedule of Changes in Estimated Fair Value of Holdback Liabilities (Details) Details 43 false false R44.htm 9955531 - Disclosure - Financial Instruments - Schedule of Fair Value and Amortized Cost of Cash Equivalents and Available-for-sale Investments by Major Security Type (Details) Sheet http://mirumpharma.com/role/FinancialInstrumentsScheduleofFairValueandAmortizedCostofCashEquivalentsandAvailableforsaleInvestmentsbyMajorSecurityTypeDetails Financial Instruments - Schedule of Fair Value and Amortized Cost of Cash Equivalents and Available-for-sale Investments by Major Security Type (Details) Details 44 false false R45.htm 9955532 - Disclosure - Financial Instruments - Contractual Maturities of Available-For-Sale Debt Securities (Details) Sheet http://mirumpharma.com/role/FinancialInstrumentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails Financial Instruments - Contractual Maturities of Available-For-Sale Debt Securities (Details) Details 45 false false R46.htm 9955533 - Disclosure - Financial Instruments - Additional Information (Details) Sheet http://mirumpharma.com/role/FinancialInstrumentsAdditionalInformationDetails Financial Instruments - Additional Information (Details) Details 46 false false R47.htm 9955534 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details) Sheet http://mirumpharma.com/role/BalanceSheetComponentsScheduleofInventoryDetails Balance Sheet Components - Schedule of Inventory (Details) Details 47 false false R48.htm 9955535 - Disclosure - Balance Sheet Components - Schedule of Finite Lived Intangible Assets (Details) Sheet http://mirumpharma.com/role/BalanceSheetComponentsScheduleofFiniteLivedIntangibleAssetsDetails Balance Sheet Components - Schedule of Finite Lived Intangible Assets (Details) Details 48 false false R49.htm 9955536 - Disclosure - Balance Sheet Components - Additional Information (Details) Sheet http://mirumpharma.com/role/BalanceSheetComponentsAdditionalInformationDetails Balance Sheet Components - Additional Information (Details) Details 49 false false R50.htm 9955537 - Disclosure - Balance Sheet Components - Schedule of Estimated Future Amortization Expense Associated with Intangible Assets (Details) Sheet http://mirumpharma.com/role/BalanceSheetComponentsScheduleofEstimatedFutureAmortizationExpenseAssociatedwithIntangibleAssetsDetails Balance Sheet Components - Schedule of Estimated Future Amortization Expense Associated with Intangible Assets (Details) Details 50 false false R51.htm 9955538 - Disclosure - Balance Sheet Components -Schedule of Accrued Expenses (Details) Sheet http://mirumpharma.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails Balance Sheet Components -Schedule of Accrued Expenses (Details) Details 51 false false R52.htm 9955539 - Disclosure - Balance Sheet Components - Schedule of Noncurrent Liabilities (Details) Sheet http://mirumpharma.com/role/BalanceSheetComponentsScheduleofNoncurrentLiabilitiesDetails Balance Sheet Components - Schedule of Noncurrent Liabilities (Details) Details 52 false false R53.htm 9955540 - Disclosure - Asset Acquisitions - Narrative (Details) Sheet http://mirumpharma.com/role/AssetAcquisitionsNarrativeDetails Asset Acquisitions - Narrative (Details) Details 53 false false R54.htm 9955541 - Disclosure - Asset Acquisitions - Schedule of Consideration Paid and Allocation of Purchase Price for Acquisition (Details) Sheet http://mirumpharma.com/role/AssetAcquisitionsScheduleofConsiderationPaidandAllocationofPurchasePriceforAcquisitionDetails Asset Acquisitions - Schedule of Consideration Paid and Allocation of Purchase Price for Acquisition (Details) Details 54 false false R55.htm 9955542 - Disclosure - License Agreements (Details) Sheet http://mirumpharma.com/role/LicenseAgreementsDetails License Agreements (Details) Details http://mirumpharma.com/role/LicenseAgreements 55 false false R56.htm 9955543 - Disclosure - Leases - Narrative (Details) Sheet http://mirumpharma.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 56 false false R57.htm 9955544 - Disclosure - Leases - Schedule of Company’s Operating Leases (Details) Sheet http://mirumpharma.com/role/LeasesScheduleofCompanysOperatingLeasesDetails Leases - Schedule of Company’s Operating Leases (Details) Details 57 false false R58.htm 9955545 - Disclosure - Leases - Schedule of Undiscounted Future Minimum Payments under Operating Leases (Details) Sheet http://mirumpharma.com/role/LeasesScheduleofUndiscountedFutureMinimumPaymentsunderOperatingLeasesDetails Leases - Schedule of Undiscounted Future Minimum Payments under Operating Leases (Details) Details 58 false false R59.htm 9955546 - Disclosure - Convertible Notes - Additional Information (Details) Notes http://mirumpharma.com/role/ConvertibleNotesAdditionalInformationDetails Convertible Notes - Additional Information (Details) Details 59 false false R60.htm 9955547 - Disclosure - Convertible Notes - Schedule Of Convertible Notes (Details) Notes http://mirumpharma.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails Convertible Notes - Schedule Of Convertible Notes (Details) Details 60 false false R61.htm 9955548 - Disclosure - Convertible Notes - Schedule of Interest Expense Related to Convertible Notes (Details) Notes http://mirumpharma.com/role/ConvertibleNotesScheduleofInterestExpenseRelatedtoConvertibleNotesDetails Convertible Notes - Schedule of Interest Expense Related to Convertible Notes (Details) Details 61 false false R62.htm 9955549 - Disclosure - Stockholders' Equity - Additional Information (Details) Sheet http://mirumpharma.com/role/StockholdersEquityAdditionalInformationDetails Stockholders' Equity - Additional Information (Details) Details 62 false false R63.htm 9955550 - Disclosure - Stockholders' Equity - Schedule of Common Stock Reserved for Issuance (Details) Sheet http://mirumpharma.com/role/StockholdersEquityScheduleofCommonStockReservedforIssuanceDetails Stockholders' Equity - Schedule of Common Stock Reserved for Issuance (Details) Details 63 false false R64.htm 9955551 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details) Sheet http://mirumpharma.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails Stock-Based Compensation - Schedule of Stock Option Activity (Details) Details 64 false false R65.htm 9955552 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://mirumpharma.com/role/StockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 65 false false R66.htm 9955553 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards Granted (Details) Sheet http://mirumpharma.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsGrantedDetails Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards Granted (Details) Details 66 false false R67.htm 9955554 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details) Sheet http://mirumpharma.com/role/StockBasedCompensationScheduleofRSUActivityDetails Stock-Based Compensation - Schedule of RSU Activity (Details) Details 67 false false R68.htm 9955555 - Disclosure - Stock-Based Compensation - Schedule of PSU Activity (Details) Sheet http://mirumpharma.com/role/StockBasedCompensationScheduleofPSUActivityDetails Stock-Based Compensation - Schedule of PSU Activity (Details) Details 68 false false R69.htm 9955556 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation Reflected in Unaudited Condensed Consolidated Statements of Operations (Details) Sheet http://mirumpharma.com/role/StockBasedCompensationSummaryofStockbasedCompensationReflectedinUnauditedCondensedConsolidatedStatementsofOperationsDetails Stock-Based Compensation - Summary of Stock-based Compensation Reflected in Unaudited Condensed Consolidated Statements of Operations (Details) Details 69 false false R70.htm 9955557 - Disclosure - Segment Reporting - Narrative (Details) Sheet http://mirumpharma.com/role/SegmentReportingNarrativeDetails Segment Reporting - Narrative (Details) Details 70 false false R71.htm 9955558 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) Sheet http://mirumpharma.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) Details 71 false false R72.htm 9955559 - Disclosure - Commitments and Contingencies (Details) Sheet http://mirumpharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://mirumpharma.com/role/CommitmentsandContingencies 72 false false All Reports Book All Reports mirm-20260630.htm mirm-20260630.xsd mirm-20260630_cal.xml mirm-20260630_def.xml mirm-20260630_lab.xml mirm-20260630_pre.xml http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true